These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 22658981

  • 1. The reduction of superoxide dismutase activity is associated with the severity of neurological soft signs in patients with schizophrenia.
    Raffa M, Fendri C, Ben Othmen L, Slama H, Amri M, Kerkeni A, Mechri A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct 01; 39(1):52-6. PubMed ID: 22658981
    [Abstract] [Full Text] [Related]

  • 2. Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients.
    Raffa M, Mechri A, Othman LB, Fendri C, Gaha L, Kerkeni A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct 01; 33(7):1178-83. PubMed ID: 19576938
    [Abstract] [Full Text] [Related]

  • 3. [Neurological soft signs in schizophrenic patients and their nonaffected siblings].
    Mechri A, Slama H, Bourdel MC, Chebel S, Mandhouj O, Krebs MO, Gaha L.
    Encephale; 2008 Oct 01; 34(5):483-9. PubMed ID: 19068337
    [Abstract] [Full Text] [Related]

  • 4. Altered antioxidant defense system in clinically stable patients with schizophrenia and their unaffected siblings.
    Ben Othmen L, Mechri A, Fendri C, Bost M, Chazot G, Gaha L, Kerkeni A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan 01; 32(1):155-9. PubMed ID: 17804133
    [Abstract] [Full Text] [Related]

  • 5. Neurological soft signs in obsessive-compulsive disorder: the effect of co-morbid psychosis and evidence for familiality.
    Peng ZW, Xu T, Miao GD, He QH, Zhao Q, Dazzan P, Chan RC.
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct 01; 39(1):200-5. PubMed ID: 22735396
    [Abstract] [Full Text] [Related]

  • 6. Association between neurological soft signs and antioxidant enzyme activity in schizophrenic patients.
    Miljević ČD, Nikolić-Kokić A, Blagojević D, Milovanović M, Munjiza A, Jukić MM, Pešić V, Lečić-Toševski D, Spasić MB.
    Psychiatry Res; 2018 Nov 01; 269():746-752. PubMed ID: 30273900
    [Abstract] [Full Text] [Related]

  • 7. [Neurological soft signs in early onset schizophrenia].
    Bourgou Gaha S, Halayem Dhouib S, Amado I, Bouden A.
    Encephale; 2015 Jun 01; 41(3):209-14. PubMed ID: 24854724
    [Abstract] [Full Text] [Related]

  • 8. Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics.
    Zhang XY, Tan YL, Cao LY, Wu GY, Xu Q, Shen Y, Zhou DF.
    Schizophr Res; 2006 Jan 31; 81(2-3):291-300. PubMed ID: 16309894
    [Abstract] [Full Text] [Related]

  • 9. Adaptive response in the antioxidant defence system in the course and outcome in first-episode schizophrenia patients: a 12-months follow-up study.
    Ruiz-Litago F, Seco J, Echevarría E, Martínez-Cengotitabengoa M, Gil J, Irazusta J, González-Pinto AM.
    Psychiatry Res; 2012 Dec 30; 200(2-3):218-22. PubMed ID: 22884309
    [Abstract] [Full Text] [Related]

  • 10. Antioxidant enzyme and malondialdehyde levels in patients with social phobia.
    Atmaca M, Kuloglu M, Tezcan E, Ustundag B.
    Psychiatry Res; 2008 May 30; 159(1-2):95-100. PubMed ID: 18339429
    [Abstract] [Full Text] [Related]

  • 11. Reduced antioxidant defense systems in schizophrenia and bipolar I disorder.
    Raffa M, Barhoumi S, Atig F, Fendri C, Kerkeni A, Mechri A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec 03; 39(2):371-5. PubMed ID: 22841966
    [Abstract] [Full Text] [Related]

  • 12. Neurological soft signs and brain morphology in first-episode schizophrenia.
    Thomann PA, Wüstenberg T, Santos VD, Bachmann S, Essig M, Schröder J.
    Psychol Med; 2009 Mar 03; 39(3):371-9. PubMed ID: 18578894
    [Abstract] [Full Text] [Related]

  • 13. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations.
    Erkiliç K, Evereklioglu C, Cekmen M, Ozkiris A, Duygulu F, Dogan H.
    Mediators Inflamm; 2003 Apr 03; 12(2):107-16. PubMed ID: 12775361
    [Abstract] [Full Text] [Related]

  • 14. Nitrite content and antioxidant enzyme levels in the blood of schizophrenia patients.
    Srivastava N, Barthwal MK, Dalal PK, Agarwal AK, Nag D, Srimal RC, Seth PK, Dikshit M.
    Psychopharmacology (Berl); 2001 Nov 03; 158(2):140-5. PubMed ID: 11702087
    [Abstract] [Full Text] [Related]

  • 15. Correlation analysis confirms differences in antioxidant defence in the blood of types I and II schizophrenic male patients treated with anti-psychotic medication.
    Miljević C, Nikolić-Kokić A, Saicić ZS, Milosavljević M, Blagojević D, Tosevski DL, Jones DR, Spasić MB.
    Psychiatry Res; 2010 Jun 30; 178(1):68-72. PubMed ID: 20452039
    [Abstract] [Full Text] [Related]

  • 16. Glutathione peroxidase, reduced glutathione, superoxide dismutase and catalase in red cells of patients with hairy cell leukemia.
    Arruda VR, Salles TS, Costa FF, Saad ST.
    Neoplasma; 1996 Jun 30; 43(2):99-102. PubMed ID: 8843970
    [Abstract] [Full Text] [Related]

  • 17. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients.
    Likidlilid A, Patchanans N, Peerapatdit T, Sriratanasathavorn C.
    J Med Assoc Thai; 2010 Jun 30; 93(6):682-93. PubMed ID: 20572373
    [Abstract] [Full Text] [Related]

  • 18. Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer.
    Kaynar H, Meral M, Turhan H, Keles M, Celik G, Akcay F.
    Cancer Lett; 2005 Sep 28; 227(2):133-9. PubMed ID: 16112416
    [Abstract] [Full Text] [Related]

  • 19. Cerebellar substructures and neurological soft signs in first-episode schizophrenia.
    Thomann PA, Roebel M, Dos Santos V, Bachmann S, Essig M, Schröder J.
    Psychiatry Res; 2009 Aug 30; 173(2):83-7. PubMed ID: 19540731
    [Abstract] [Full Text] [Related]

  • 20. Neurological soft signs and schizotypal dimensions in unaffected siblings of patients with schizophrenia.
    Mechri A, Gassab L, Slama H, Gaha L, Saoud M, Krebs MO.
    Psychiatry Res; 2010 Jan 30; 175(1-2):22-6. PubMed ID: 19959242
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.